PROCLAIM-CX-072
Showing 1 - 25 of 101
Solid Tumor, Unresectable or Metastatic Melanoma Trial in Worldwide (CX-072, Ipilimumab)
Terminated
- Solid Tumor
- Unresectable or Metastatic Melanoma
-
Duarte, California
- +26 more
Nov 2, 2021
Breast Cancer Metastatic Trial in Worldwide (MCLA-128, Trastuzumab, Vinorelbine)
Active, not recruiting
- Breast Cancer Metastatic
- MCLA-128
- +3 more
-
Los Angeles, California
- +24 more
Aug 10, 2022
Selected Advanced Solid Tumors Trial in Worldwide (MEDI5752, Pemetrexed, Carboplatin)
Recruiting
- Selected Advanced Solid Tumors
- MEDI5752
- +4 more
-
Detroit, Michigan
- +40 more
Oct 31, 2022
Validation of the European Oncology Quality of Life Toolkit
Not yet recruiting
- Cancer
- +2 more
- Administration of the EUonQoL-Kit - Active Treatment questionnaire
- +2 more
-
Tirana, Albania
- +44 more
Jul 17, 2023
COVID-19 Trial in Taipei (CX-4945)
Active, not recruiting
- COVID-19
-
Taipei, TaiwanTaipei Medical University Hospital
Apr 16, 2023
TARGET Post-Approval Study
Active, not recruiting
- Complex Regional Pain Syndrome (CRPS)
- Dorsal Root Ganglion (DRG) Stimulation (Axium™ Neurostimulator System)
- Dorsal Root Ganglion (DRG) Stimulation (Proclaim™ Neurostimulator System)
-
Scottsdale, Arizona
- +44 more
Apr 6, 2022
Prostate Cancer Trial in United States (Invitae multi-cancer gene panel)
Completed
- Prostate Cancer
- Invitae multi-cancer gene panel
-
San Diego, California
- +18 more
Jul 1, 2022
Solid Tumors Trial in Nashville (CX-904)
Recruiting
- Solid Tumors
-
Nashville, TennesseeSarah Cannon Research Institute, LLC
May 19, 2022
Triple Negative Breast Cancer, TNBC - Triple-Negative Breast Cancer Trial in United States (Paclitaxel, CB-839)
Completed
- Triple Negative Breast Cancer
- TNBC - Triple-Negative Breast Cancer
-
Birmingham, Alabama
- +24 more
Sep 19, 2022
Non-GCB/ABC DLBCL, With and Without MyD88 and/or CD79B Mutations Trial in Cleveland, Toledo (Mivavotinib)
Recruiting
- Non-GCB/ABC Diffuse Large B-Cell Lymphoma
- With and Without MyD88 and/or CD79B Mutations
-
Evanston, Illinois
- +6 more
Dec 12, 2022
Calcified Atheroma Trial (Electrohydraulic shock wave lithotripsy, Rotary atherectomy)
Not yet recruiting
- Calcified Atheroma
- Electrohydraulic shock wave lithotripsy
- Rotary atherectomy
- (no location specified)
Feb 7, 2023
Advanced NSCLC, EGFR Mutation, HER2 Mutation Trial in Worldwide (BAY2927088_formulation A, BAY2927088_formulation B_1,
Recruiting
- Advanced Non-small Cell Lung Cancer
- +2 more
- BAY2927088_formulation A
- +2 more
-
Gilbert, Arizona
- +75 more
Jan 16, 2023
Coronary Artery Disease Trial in Antwerp, Genk, Sao Paulo (DESolve Cx drug eluting coronary scaffold system)
Completed
- Coronary Artery Disease
- DESolve Cx drug eluting coronary scaffold system
-
Antwerp, Belgium
- +2 more
Jul 13, 2021
Leukemia, Myeloid, Acute Trial in Worldwide (AG-120, Azacitidine, AG-221)
Active, not recruiting
- Leukemia, Myeloid, Acute
- AG-120
- +2 more
-
Duarte, California
- +72 more
Aug 18, 2022
Acute Myeloid Leukemia Trial in United States (CX-01, Idarubicin, Cytarabine)
Clostridium Difficile Trial in Saint Louis, Chapel Hill, Nashville (Misoprostol 100Mcg Tab, Placebo)
Completed
- Clostridium Difficile
- Misoprostol 100Mcg Tab
- Placebo
-
Saint Louis, Missouri
- +2 more
Mar 2, 2022